Opportunity knocks for big pharmaceutical companies in the credit crunchAlthough the credit crunch has left non-financial services companies, including those …
Pfizer is repackaging its medicines in a bid to make dosing instructions clearer. The National Patient Safety Agency (NPSA) estimates …
The Healthcare Commission's third yearly snapshot of the NHS in England shows a significant increase in trusts performing well, but …
MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …
Daiichi-Sankyo and Lilly have responded to media speculation around the FDA's make-or-break ruling on their major new drug prasugrel. The …
The government is investing £5 million in specialist research projects on the planning and provision of health services. The new …
The European future of Wyeth’s depression treatment Ellefore has been thrown into doubt after the pharma company withdrew its application …
GlaxoSmithKline has extended its reach into emerging markets by acquiring Bristol-Myers Squibb’s Egyptian mature products business for £125 millionThe move …
Contract research organisations are now play a key role in the development of most of the industry's drugs, with some …
NICE has spurned GSK's risk-sharing proposal for its breast cancer treatment Tyverb, saying the drug is still too expensive to …
Oxford BioMedica has settled on a permanent chief executive, promoting John Dawson from his acting leadership position. Chairman professor Alan …

A collective of European legislators, patient groups and the pharma industry have reiterated the call for Europe’s ban on pharma …
Johnson & Johnson has named a new chairman for its struggling pharmaceuticals group, and kept the role under female leadership. …
How did you get into your current role After completing my D.Phil at Oxford, I looked for an opportunity in …
Battle for HIV drug market share getting fiercerThe HIV market, worth $9.3 billion in 2007, is expected to grow to …
AstraZeneca's head of global drug discovery Jan Lundberg says his younger years as a sportsman have made him a determined …
Novartis says new data on Glivec shows it has potential to treat a life-threatening heart condition, despite failing to meet …
A new report from the World Health Organisation says England's mental health care has undergone a 'transformation' in the last …